Human Lyme Disease Vaccine in Final Clinical Trial

Twenty years after the last human Lyme disease vaccine was pulled from the market, outdoor enthusiasts could get a new vaccine to protect against the widespread tick-borne illness.

According to NPR, the new Lyme vaccine candidate is called VLA15 and it entered its third phase of a clinical trial in humans this week. The vaccine aims to protect people as young as five.

Though it’s expected to take years to reach the market, VLA15 would become the only vaccine for Lyme disease available to humans in the United States, if approved.

Read more at Newsmax© 2022 Newsmax. All rights reserved.

There is no custom code to display.